Samsung Biologics to Acquire PolyPeptide for CHF 1.46B
INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...
Pharmaceutical Manufacturing
Advertisement
Insilico Medicine Partners Bora for AI Drug Innovation
HONG KONG & TAIPEI, Taiwan, July 14, 2026 Insilico Medicine and Bora Pharmaceuticals Co., Ltd. have announced a landmark...
Novo Nordisk’s Denecimig Shows Strong Phase 3 Hemophilia Data
PLAINSBORO, New Jersey, USA / BAGSVÆRD, Denmark, July 11, 2026 Novo Nordisk has announced positive long-term Phase 3 results...
FDA Proposes New Rule to Modernize Drug Manufacturing
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
WuXi Biologics MFG8 Secures FDA PLI for Autoimmune Therapy
HEBEI, China | July 9, 2026 WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has...
Advertisements
Codis Expands European CDMO with Catalent Acquisition
HAVERHILL, United Kingdom, July 6, 2026 Codis announced an agreement to acquire Catalent Pharma Solutions’ Nottingham, UK facility, a...
Vector Secures Exclusive cGMP Peptide Manufacturing Deal
MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...
FDA Selects Seven Firms for PreCheck Manufacturing Pilot
SILVER SPRING, Md., June 29, 2026 The U.S. Food and Drug Administration (FDA) has announced the selection of seven...
LOTTE Biologics Completes Songdo Plant 1 Construction
INCHEON, South Korea and SAN DIEGO, June 21, 2026 LOTTE Biologics has announced the successful completion of major construction...
Lupin Receives US FDA EIR for Ankleshwar Manufacturing Site
MUMBAI, India, May 28, 2026 Lupin Limited, one of the world’s leading pharmaceutical companies, has announced that it has...
Advertisement
